Brickell Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Brickell Biotech's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 78% to $404,000. Profit margin reached -9788%. Total operating expenses were $40,648,000.

Profit Margin

Brickell Biotech, Inc. (NASDAQ:BBI): Profit margin
2012 17.51M -22.89M -130.71%
2013 7.71M -31.23M -404.74%
2014 15.21M -16.49M -108.38%
2015 20.95M -9.23M -44.1%
2016 14.53M -8.97M -61.75%
2017 13.81M -12.96M -93.78%
2018 1.62M -16.25M -1002.1%
2019 7.91M -23.87M -301.59%
2020 1.82M -20.91M -1147.8%
2021 404K -39.54M -9787.87%

BBI Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
404K1.82M7.91M1.62M13.81M14.53M20.95M15.21M7.71M17.51M
Cost of revenue
0001.43M6.47M6.29M10.92M10.82M12.69M0
Gross profit
404K1.82M7.91M186K7.34M8.24M10.02M4.39M-4.98M17.51M
Operating exp.
Research and development
28.23M11.21M20.21M12.32M14.39M10.35M11.06M11.46M14.55M17.34M
Selling and marketing
0001.43M6.47M6.29M10.92M10.82M12.69M13.05M
Total operating expenses
40.64M22.79M32.38M21.26M27.20M23.70M30.35M31.84M39.07M40.95M
Operating income
-39.40M-20.97M-24.46M-19.64M-13.38M-9.17M-9.40M-16.62M-31.35M-23.43M
Other income (expenses), net
-69K63K591K3.39M426K204K166K134K114K534K
Income before tax
-39.47M-20.91M-23.87M-16.25M-12.96M-8.97M-9.23M-16.49M-31.23M-22.89M
Income tax expense
69K63K2.68M4.48M426K204K166K134K114K0
Net income
-39.54M-20.91M-23.87M-16.25M-12.96M-8.97M-9.23M-16.49M-31.23M-22.89M
Earnings per share
Basic EPS
-22.16-38.39-355.43-234.41-316.76-282.12-317.16-585.11-1.13K-850.50
Diluted EPS
-22.16-38.39-355.43-234.41-316.76-282.12-317.16-585.11-1.13K-850.50
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source